Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer

被引:106
作者
Rexhepaj, Elton [1 ]
Brennan, Donal J. [2 ]
Holloway, Peter [2 ]
Kay, Elaine W. [3 ]
McCann, Amanda H. [2 ]
Landberg, Goran [4 ]
Duffy, Michael J. [2 ,5 ]
Jirstrom, Karin [4 ]
Gallagher, William M. [1 ]
机构
[1] Univ Coll Dublin, UCD Conway Inst, UCD Sch Biomol & Biomed Sci, Dublin 4, Ireland
[2] Univ Coll Dublin, UCD Conway Inst, UCD Sch Med & Med Sci, Dublin 4, Ireland
[3] Beaumont Hosp, Royal Coll Surg Ireland, Educ & Res Ctr, Dept Histopathol, Dublin 9, Ireland
[4] Lund Univ, Malmo Univ Hosp, Dept Lab Med, Ctr Mol Pathol, Malmo, Sweden
[5] St Vincents Univ Hosp, Dept Pathol & Lab Med, Dublin 4, Ireland
关键词
D O I
10.1186/bcr2187
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Introduction Manual interpretation of immunohistochemistry (IHC) is a subjective, time-consuming and variable process, with an inherent intra-observer and inter-observer variability. Automated image analysis approaches offer the possibility of developing rapid, uniform indicators of IHC staining. In the present article we describe the development of a novel approach for automatically quantifying oestrogen receptor (ER) and progesterone receptor (PR) protein expression assessed by IHC in primary breast cancer. Methods Two cohorts of breast cancer patients (n = 743) were used in the study. Digital images of breast cancer tissue microarrays were captured using the Aperio ScanScope XT slide scanner (Aperio Technologies, Vista, CA, USA). Image analysis algorithms were developed using MatLab 7 (MathWorks, Apple Hill Drive, MA, USA). A fully automated nuclear algorithm was developed to discriminate tumour from normal tissue and to quantify ER and PR expression in both cohorts. Random forest clustering was employed to identify optimum thresholds for survival analysis. Results The accuracy of the nuclear algorithm was initially confirmed by a histopathologist, who validated the output in 18 representative images. In these 18 samples, an excellent correlation was evident between the results obtained by manual and automated analysis (Spearman's rho = 0.9, P < 0.001). Optimum thresholds for survival analysis were identified using random forest clustering. This revealed 7% positive tumour cells as the optimum threshold for the ER and 5% positive tumour cells for the PR. Moreover, a 7% cutoff level for the ER predicted a better response to tamoxifen than the currently used 10% threshold. Finally, linear regression was employed to demonstrate a more homogeneous pattern of expression for the ER (R = 0.860) than for the PR (R = 0.681). Conclusions In summary, we present data on the automated quantification of the ER and the PR in 743 primary breast tumours using a novel unsupervised image analysis algorithm. This novel approach provides a useful tool for the quantification of biomarkers on tissue specimens, as well as for objective identification of appropriate cutoff thresholds for biomarker positivity. It also offers the potential to identify proteins with a homogeneous pattern of expression.
引用
收藏
页数:10
相关论文
共 32 条
[1]
Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0
[2]
Tissue microarrays: bridging the gap between research and the clinic [J].
Braunschweig, T ;
Chung, JY ;
Hewitt, SM .
EXPERT REVIEW OF PROTEOMICS, 2005, 2 (03) :325-336
[3]
Application of DNA microarray technology in determining breast cancer prognosis and therapeutic response [J].
Brennan, DJ ;
O'Brien, SL ;
Fagan, A ;
Culhane, AC ;
Higgins, DG ;
Duffy, MJ ;
Gallagher, WM .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (08) :1069-1083
[4]
Brennan Donal J., 2007, Cancer Genomics & Proteomics, V4, P121
[5]
Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer [J].
Brennan, Donal J. ;
Rexhepaj, Elton ;
O'Brien, Sallyann L. ;
McSherry, Elaine ;
O'Connor, Darran P. ;
Fagan, Ailis ;
Culhane, Aedin C. ;
Higgins, Desmond G. ;
Jirstrom, Karin ;
Millikan, Robert C. ;
Landberg, Goran ;
Duffy, Michael J. ;
Hewitt, Stephen M. ;
Gallaghe, William M. .
CLINICAL CANCER RESEARCH, 2008, 14 (09) :2681-2689
[6]
CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance [J].
Brennan, Donal J. ;
Jirstrom, Karin ;
Kronblad, Asa ;
Millikan, Robert C. ;
Landberg, Goran ;
Duffy, Michael J. ;
Ryden, Lisa ;
Gallagher, William M. ;
O'Brien, Sallyann L. .
CLINICAL CANCER RESEARCH, 2006, 12 (21) :6421-6431
[7]
Prognostic ability of a panel of immunohistochemistry markers - retailoring of an 'old solution' [J].
Brennan, Donal J. ;
Gallagher, William M. .
BREAST CANCER RESEARCH, 2008, 10 (01)
[8]
Automated subcellular localization and quantification of protein expression in tissue microarrays [J].
Camp, RL ;
Chung, GG ;
Rimm, DL .
NATURE MEDICINE, 2002, 8 (11) :1323-1327
[9]
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study [J].
Carey, Lisa A. ;
Perou, Charles M. ;
Livasy, Chad A. ;
Dressler, Lynn G. ;
Cowan, David ;
Conway, Kathleen ;
Karaca, Gamze ;
Troester, Melissa A. ;
Tse, Chiu Kit ;
Edmiston, Sharon ;
Deming, Sandra L. ;
Geradts, Joseph ;
Cheang, Maggie C. U. ;
Nielsen, Torsten O. ;
Moorman, Patricia G. ;
Earp, H. Shelton ;
Millikan, Robert C. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (21) :2492-2502
[10]
Quantitative analysis of estrogen receptor heterogeneity in breast cancer [J].
Chung, Gina G. ;
Zerkowski, Maciej P. ;
Ghosh, Sriparna ;
Camp, Robert L. ;
Rimm, David L. .
LABORATORY INVESTIGATION, 2007, 87 (07) :662-669